Products

What will AGI do for Anisindione?

This classification denotes an anticoagulant agent with the molecular formula C16H12O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S747T1ERAJ, chemically known as 1,3-indanedione, 2-(4-methoxyphenyl)- but generally known as anisindione, which bears US NIH Compound Identifier 2197. European Medicines Agency schedules Anisindione in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05520MIG. The term ANISINDIONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). ANISINDIONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule anisindione under HS 29145000 and SITC 51629. As of Q4 2014, ANISINDIONE remains the US FDA Preferred Term for this commodity. Anisindione bears US NLM identifiers UMLS ID C0051919 and NCI Concept Code C47398. SMILES: O=C1C(C(=O)C2C1CCCC2)C1CCC(OC)CC1.

How AGI delivers it

Four ways AGI delivers for Anisindione

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Anisindione, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Anisindione, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Anisindione connects

measured by

  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Impurity Profilemodel
  • Melting Pointmodel
  • Particle Size Distributionmodel
  • Residual Solventmodel